Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
69.41
+2.30 (3.43%)
Nov 7, 2025, 12:03 PM EST - Market open
Revenue by Geography
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
|---|
| 988.45M | 1.01B | | | | |
| 63.94M | 62.41M | | | | |
| 170.29M | 175.66M | | | | |
| 90.97M | 92.31M | | | | |
| 14.21M | 19.54M | | | | |
| 1.33B | 1.36B | | | | |
Revenue Breakdown
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
|---|
Plasma Products and Services Revenue | - | - | | | | |
Blood Center Products and Services Revenue | - | - | | | | |
Hospital Products and Services Revenue | - | - | | | | |
| 1.33B | 1.36B | | | | |
| 1.33B | 1.36B | | | | |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
|---|
| 516.22M | 535.43M | | | | |
| 234.64M | 261.12M | | | | |
| 576.99M | 564.27M | | | | |
| - | - | | | | |
Effect of Exchange Rates on Revenue | - | - | | | | |
| 1.33B | 1.36B | | | | |
EBIT
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
|---|
Plasma Segment Operating Income (Post-Q3 2025 Reporting) | - | 184.51M | | | | |
Blood Center Segment Operating Income (Post-Q3 2025 Reporting) | - | 52.82M | | | | |
Hospital Segment Operating Income (Post-Q3 2025 Reporting) | - | 88.98M | | | | |
| 230.68M | -104.49M | | | | |
| 230.68M | 221.82M | | | | |
EBIT 2
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
|---|
Plasma Segment Operating Income | - | - | | | | |
Blood Center Segment Operating Income | - | - | | | | |
Hospital Segment Operating Income | - | - | | | | |
| 230.68M | 221.82M | | | | |
Updated Nov 6, 2025. Data Source:
Fiscal.ai.